Hypertensive leg ulcers (Martorell's ulcers) are a unique form of lower extremity ischaemic leg ulcer. First described by Martorell, and Hines and Farber in the 1940s, these ulcers are defined by pain disproportionate to the size of the ulcer, specific location on the lower extremity, female-to-male predominance, association with long-standing, often poorly, controlled hypertension, and healing response to specific antihypertensive
Introduction
Ulcers of the lower extremities are commonly due to arterial insufficiency (eg, atherosclerosis) and venous stasis. There is also a type of ischaemic ulcer that occurs uniquely in the hypertensive patient. First described by Martorell, and Hines and Farber in the 1940s, these ulcers are defined by pain disproportionate to the size of the ulcer, unique location in the lower extremities, female-to-male predominance, and their association with long-standing, often poorly controlled hypertension. Recognition of hypertensive ischaemic leg (Martorell's) ulcers and the initiation of effective antihypertensive therapy result in the resolution of these debilitating lesions. We present a case of Martorell's hypertensive ischaemic leg ulcer and a concise review of the 104 cases previously described in the world's literature.
Case
A 67-year-old white female with a history of peripheral vascular disease was referred by her local physician for treatment of a non-healing leg ulcer of 4 months' duration. In 1996, she had an aortobifemoral (ABF) bypass graft for claudication. She underwent a left leg femoral-popliteal bypass in July 1997 for nonpainful ulcers of the left leg and the ulcers resolved. In August of 1998, she developed right leg claudication, and an arteriogram showed occlusion of the right limb of the ABF graft and a right femoral-femoral graft was done with relief of claudication.
She travelled to Europe and, while there, developed a very painful ulcer of the lower right leg without claudication symptoms. She saw her local doctor on return to Minnesota. Local wound care and 2 weeks of oral Ciprofloxacin did not improve the ulcer. She was seen in a wound centre in Minneapolis and noninvasive Doppler studies revealed good flow in the right leg graft. Topical therapy with Silvadene and Sorbsan and oral therapy with pentoxifylline and cephalosporin was instituted. The ulcer remained extremely painful and unchanged in size despite these measures, and she was referred to the Mayo Clinic for further evaluation.
She had been taking hypertensive medications for more than 5 years. She had not measured home blood pressures, so her previous degree of blood pressure control was unclear but was suspected to be poor. Medications were verapamil 240 mg/day, simvastatin 5 mg/day, pentoxifylline 400 mg t.i.d., warfarin 5 mg 5 days/week and 2.5 mg 2 days/week, ranitidine 150 mg/day, calcium 1500 mg/day and a multivitamin one daily. ( Figure 1 ). The base was covered by fibrinous exudate with some buds of granulation and sharply demarcated margins. There was trace oedema of the lower extremities bilaterally. The pulses in the right leg were 2+ femoral and absent distal to the femoral pulse.
Physical exam

Laboratory studies
X-ray of the right foot and ankle was negative for osteomyelitis. Ultrasound revealed the right femoralfemoral bypass graft to be patent with an arterial flow of 52-60 cm/sec in the right popliteal artery. WBC 7000, haemoglobin 14.1 g/dL, fasting glucose 93 mg/dL, serum creatinine 1.4 mg/dL, serum protein electrophoresis was normal, and homocysteine level was 14 umol/L (N Ͻ13 mol/L).
Course
The patient was seen at the Wound Centre, her Sorbsan was discontinued and saline gauze dressings (which she had used previously without effect), a Rooke boot and reduced ambulation were prescribed. Enalapril/hydrochlorothiazide 5/12.5 mg once daily was prescribed. No further changes were made in her therapy, and her course over the next 7 weeks was excellent. Three weeks later, the patient returned and her blood pressure was 133/58 mm Hg. The ulcer was reduced in size to 1.4 × 1.3 cm and was less painful (Figure 2 ). At 5 weeks after her initial visit, her blood pressure was 142/70 mm Hg. By 7 weeks after the initial visit, the ulcer had 100% epithelialization and the patient was pain free ( Figure 3 ).
Discussion
First described by venous disease of the lower extremity, a painful ulcer on the antero-exterior surface of the lower twothirds of the leg, and lesions that are often symmetrically present in the lower extremities. Our patient is the 105th case of hypertensive leg ulcer in the world's literature, and this case demonstrates many of the cardinal findings of hypertensive ischaemic ulcers.
Our case (a woman in her mid-60s) is almost identical to Martorell's index case of hypertensive ischaemic leg ulcer and representative of the demographics of age and gender in the cases in the literature. Of the 105 cases of Martorell's' ulcer; 82 are female and 23 male, the first male case being reported by Valls-Serra in 1950. 3 There are only three cases reported in African-Americans and all are females. The age range for Martorell's ulcer is from 41 years of age (by Wright 3 ) to 86 years of age (by Rude   4 ). The mean age cannot be calculated, as not all reports of hypertensive leg ulcers give exact ages, but the usual age reported is mid 50s to mid 60s. The largest single series, like the initial report by Hines and Farber, 2 comes from Schnier and Sheps at the Mayo Clinic and consists of 40 patients, of which 13 were male and 27 female with ages ranging from 42 to 81 years of age.
Hypertension in Martorell's ischaemic leg ulcers is poorly controlled and often severe. In 60 of the 105 cases, the individual blood pressures were given. In these individuals, the mean systolic blood pressure was 204 mm Hg (R = 120-290) and diastolic blood pressure 115 mm Hg (R = 70-160). The highest reported blood pressure was from Monserrat's case report 6 at 290/160 mm Hg and the lowest from Henderson 7 at 120/70 mm Hg. Our patient demonstrates the distinct character and position on the lower extremity of hypertensive ischaemic leg ulcers. Their classic location is seen in Figure 4 , adapted from the paper of Schnier and Sheps. 5 These lesions are most commonly on the lateral aspects of the lower extremities and often symmetrical. These ulcers usually have been present for long periods of time and found to be refractory to the usual local measures for ulcer healing. Another characteristic feature of hypertensive ulcers is their episodic and irregular extension by skin infarction, Journal of Human Hypertension as well as the development of satellite lesions, findings not seen in our case. The extremely painful nature of hypertensive leg ulcers needs to be emphasised. Painful lower extremity ulcers may occur in a variety of conditions such as large vessel arterial occlusive disease, atheroemboli, vasculitis, after insect bites and with pyoderma gangrenosum to name just a few. 8 The pain seen with hypertensive ischaemic ulcers is frequently reported to be far more severe than would be expected for the size of the ulcer and may even be the sole reason the patient seeks medical care. 8 The pathophysiology of hypertensive ischaemic leg ulcers is felt to reflect a severe variant of the diffuse disturbance of the vascular bed that occurs in hypertension. Bell and Clausen 9 in 1928 first described the diffuse arteriolar changes seen in hypertension. Their study of 420 autopsies in patients with primary hypertension first described arteriolosclerosis in the dermal arterioles, even though it occurred far less frequently than it did in other organs such as brain and kidney. Farber and Hines 10 found a disturbance in the wall-to-lumen ratio in the dermal arterioles in patients with hypertension. In hypertensives, a measurable thickening of the arteriolar wall and a decrease in the wall-tolumen ratio was found when compared to normals. The average of the wall-to-lumen ratio of the arterioles of 52 persons with normal blood pressure was 1:2.14; among 70 persons with essential hypertension, it was 1:1.57. Hyperplasia of the nuclear elements of the media and thickening of the elastic lamina were the most common pathologic changes. These pathologic findings in hypertensives without hypertensive ischaemic leg ulcers were confirmed by Henderson et al 7 in a study of 16 consecutive patients with hypertensive ischaemic ulcers. Using the same method of arteriolar measurement as Farber and Hines, Henderson also found a significant reduction in wall-to-lumen ratio in patients with hypertensive ischaemic ulcers compared to that found in patients with other types of chronic leg ulcers. These pathologic changes probably do not, by themselves, account for the development of hypertensive ischaemic ulcers. Duncan and Farris 11 compared 12 normotensive controls and eight patients with peripheral vascular disease to six patients with Martorell's hypertensive ischaemic leg ulcers. The Martorell's leg ulcer patients had a low skin perfusion pressure compared to normal, as did the patients with peripheral vascular disease. The Martorell's leg ulcer patients also had a much higher ankle-arm ratio than did the patients with peripheral vascular disease. This suggests that the lower skin perfusion pressure in Martorell's patients was due to a local increase in vascular resistance, whereas the reduced skin perfusion pressure in peripheral vascular disease patients was due to reduction in arterial inflow to the leg. This inability to vasodilate in response to the arteriolar narrowing of hypertension may reduce tissue perfusion to a level that results in ischaemic ulcer formation; ie, Martorell's hypertensive ischaemic leg ulcer. Less severe ischaemia may, when coupled with additional insult such as trauma or macrovascular arterial disease, lead to formation of the more common vascular insufficiency ulcer. These pathophysiologic changes are important as they may explain the response of hypertensive ischaemic ulcers to different modes of antihypertensive therapy.
In the era before the availability of antihypertensive agents, numerous topical therapies were tried for hypertensive leg ulcers. These included desiccated red blood cells, 2 boric acid solution, 2 brilliant green, 6, 12 Lassar's paste, 13 sulfadiazine powder 2, 12 and topical Varidase (streptokinase-streptodornase).
14 All of these were combined with bedrest, and ulcer healing occurred, if at all, over a period of many months. Skin grafting has also used 14, 15 with some success. Other therapies applied include cod liver oil, 3 typhoid vaccine, 3 intra-arterial novocaine 16 and IV calcium thionate. 3 The ischaemic nature of these ulcers led to attempts at vasodilation via lumbar sympathectomy. First used by both Martorell 1 and Hines and Farber, 2 other authors employed lumbar sympathectomy to try and vasodilate the affected limb and improve perfusion to the ischaemic ulcer. 5, 6, 13, 15, 17, 18 All of these are anecdotal reports, and the responses to lumbar sympathectomy varied from clinical observations of distinct ulcer improvement to no evidence of benefit. Lumbar sympathectomy had little impact on systemic hypertension, so it is not surprising that sympathectomy had an uncertain impact on the ischaemia present in hypertensive leg ulcers.
The first attempt to treat hypertensive leg ulcers by blood pressure reduction was reported by Orbach. 13 In 1948, he placed one patient on a rice diet, and the blood pressure fell from 260/160 mm Hg to 160/110 mm Hg and, in combination with skin grafting, the ulcer healed over 2 months' time. The first report of antihypertensive drug therapy was from Fogola et al 16 in 1971 . They reported the use of diuretics and 'hypotensive drugs' in five patients with hypertensive ischaemic ulcers. There was no further explanation of the 'hypotensive' agents used and little obvious benefit to ulcer healing reported. Rude 4 in 1983 reported a case of hypertensive ischaemic leg ulcer treated with diuretic and methyldopa. Despite reduction of the blood pressure from 200/120 mm Hg to 130/80 mm Hg, the ulcer required topical antibiotics, skin grafting and a further 3 months to heal, suggesting little benefit was derived from successful blood pressure control. Henderson et al 7 reported 16 cases of hypertensive ischaemic leg ulcers in 1995. Nine of 16 had uncontrolled hypertension and seven controlled hypertension. The only observation made on antihypertensive therapy's impact on ulcer healing was of four cases in which stopping beta-blocker therapy improved ulcer healing. This suggested that betablockers may aggravate local vasoconstriction and impair healing of hypertensive ischaemic leg ulcers. The only randomised, placebo-controlled trial of antihypertensive therapy in patients with hypertensive ischaemic ulcers was reported in 1995 by Nikolova. 19 Thirty outpatients with hypertensive ischaemic leg ulcers were randomised to a 2-month placebo-controlled trial of nifedipine 10 mg given orally three times daily. Significant improvement in symptomatic pain and reduction in ulcer surface area occurred in the nifedipine treated subjects when compared to placebo. This difference was seen even though the reduction in blood pressure between the two groups from baseline to the end of the 2 months was only 5 mm Hg systolic (165.5 Ϯ 12.2 mm Hg for nifedipine vs 170.8 ± 13.1 mm Hg for placebo). This study supports the pathophysiology of hypertensive ischaemic ulcers as local arteriolosclerosis combined with inappropriate vasoconstriction. This study also helps explain the varying responses to antihypertensive therapy seen in hypertensive ischaemic leg ulcers. It is important to lower blood pressure to reduce further arteriolosclerosis. More importantly, to aid in ulcer healing, antihypertensive agents must also reduce local vasoconstriction as demonstrated by Nikolova with the calcium channel blocker (nifedipine) and seen in our patient with an angiotensin converting enzyme (ACE) inhibitor (enalapril). It may be that hypertensive leg ulcers are less well recognised in that therapy of patients with hypertension is dominated by the use of calcium channel blockers and ACE inhibitors.
Conclusion
In summary, hypertensive ischaemic leg ulcers (Martorell's ulcers) are a unique and under-recognised entity. Their clinical presentation of pain disproportionate to the size of the ulcer, characteristic location on the leg, absence of significant arterial or venous disease, female-to-male predominance, and association with long-standing or poorly controlled hypertension are under-recognised. Fifteen manuscripts representing 86 of the 104 previously reported cases of hypertensive ischaemic ulcers appeared in the English literature from 1945 to 1971. Only three papers in the 1980s 4, 10, 20 and three in the 1990s 7, 19, 21 mention this topic. Now that physicians of that earlier era are retiring, this disease has become again unappreciated, leading to delay in effective therapy. Three of the most commonly used hypertension textbooks do not mention hypertensive leg ulcers as a complication of long-standing or poorly controlled hypertension. [22] [23] [24] Failure to recognise this lesion leads to months of ineffective local therapy and prolonged disability due to the severe pain of hypertensive ischaemic leg ulcers, as our case demonstrates. The pathophysiology of hypertensive ischaemic ulcers, arteriolosclerosis of the dermal vessels with inappropriate local vasoconstriction is important to successful therapy. Our case's response to ACE inhibitor therapy and the work of Duncan 10 and Nikolova 19 suggest that an additional criteria for the diagnosis of hypertensive ischaemic ulcers is prompt wound healing with aggressive blood pressure therapy especially with agents that reduce arteriolar vasoconstriction. This may be similar to the microvascular disease of diabetes mellitus where a more aggressive goal blood pressure than 140/90 mm Hg and use of specific antihypertensive agents has an added benefit. Martorell's hypertensive ischaemic ulcers will be more commonly recognised by clinicians with a renewed appreciation for this clinical entity.
